{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:15:38Z","timestamp":1791512138569,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,17]],"date-time":"2024-11-17T00:00:00Z","timestamp":1731801600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["aaojournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ophthalmology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ophtha.2023.07.023","type":"journal-article","created":{"date-parts":[[2023,7,25]],"date-time":"2023-07-25T21:58:56Z","timestamp":1690322336000},"page":"1258-1268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality"],"prefix":"10.1016","volume":"130","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2967-4792","authenticated-orcid":false,"given":"John H.","family":"Kempen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Newcomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri L.","family":"Washington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6612-5653","authenticated-orcid":false,"given":"C. Stephen","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1575-0819","authenticated-orcid":false,"given":"Lucia","family":"Sobrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E.","family":"Thorne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0368-1361","authenticated-orcid":false,"given":"Douglas A.","family":"Jabs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Suhler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8452-2441","authenticated-orcid":false,"given":"James T.","family":"Rosenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Nida","family":"Sen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A.","family":"Levy-Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Nussenblatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirali P.","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Careen Y.","family":"Lowder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra A.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0997-9863","authenticated-orcid":false,"given":"Yannek I.","family":"Leiderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha R.","family":"Acharya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary N.","family":"Holland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell W.","family":"Read","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Dunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt A.","family":"Dreger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pichaporn","family":"Artornsombudh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosne A.","family":"Begum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonetta D.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3065-4975","authenticated-orcid":false,"given":"Srishti","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4484-8279","authenticated-orcid":false,"given":"Abhishek R.","family":"Payal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2027-2316","authenticated-orcid":false,"given":"Ebenezer","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5461-8568","authenticated-orcid":false,"given":"Sapna S.","family":"Gangaputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. Oktay","family":"Ka\u00e7maz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa L.","family":"Liesegang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth S.","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naira","family":"Khachatryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armin","family":"Maghsoudlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3772-4825","authenticated-orcid":false,"given":"Hilkiah K.","family":"Suga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6661-8562","authenticated-orcid":false,"given":"Clara M.","family":"Pak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathy J.","family":"Helzlsouer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine M.","family":"Buchanich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ophtha.2023.07.023_bib1","doi-asserted-by":"crossref","first-page":"b2480","DOI":"10.1136\/bmj.b2480","article-title":"Overall and cancer related mortality among patients with ocular inflammation treated with immunosuppressive drugs: retrospective cohort study","volume":"339","author":"Kempen","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.ophtha.2023.07.023_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajo.2008.04.035","article-title":"Long-term risk of malignancy among patients treated with immunosuppressive agents for ocular inflammation: a critical assessment of the evidence","volume":"146","author":"Kempen","year":"2008","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.07.023_bib3","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2017.5103","volume":"317","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.ophtha.2023.07.023_bib4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ophtha.2017.08.007","article-title":"Immunosuppression for the Uveitides","volume":"125","author":"Jabs","year":"2018","journal-title":"Ophthalmology"},{"issue":"1A","key":"10.1016\/j.ophtha.2023.07.023_bib6","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0002-9343(85)90240-2","article-title":"Cancer and rheumatoid arthritis: epidemiologic considerations","volume":"78","author":"Prior","year":"1985","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2023.07.023_bib7","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1080\/09286580701585892","article-title":"Methods for identifying long-term adverse effects of treatment in patients with eye diseases: the Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Cohort Study","volume":"15","author":"Kempen","year":"2008","journal-title":"Ophthalmic Epidemiol"},{"key":"10.1016\/j.ophtha.2023.07.023_bib8","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0002-9394(00)00659-0","article-title":"Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel","volume":"130","author":"Jabs","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ophtha.2023.07.023_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","article-title":"A\u00a0new method of classifying prognostic comorbidity in longitudinal studies: development and validation","volume":"40","author":"Charlson","year":"1987","journal-title":"J\u00a0Chronic Dis"},{"key":"10.1016\/j.ophtha.2023.07.023_bib10","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1097\/00043764-199809000-00010","article-title":"Using the National Death Index to obtain underlying cause of death codes","volume":"40","author":"Sathiakumar","year":"1998","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.ophtha.2023.07.023_bib11","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/S1047-2797(01)00285-X","article-title":"A\u00a0primer and comparative review of major US mortality databases","volume":"12","author":"Cowper","year":"2002","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ophtha.2023.07.023_bib12","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2105\/AJPH.82.8.1145","article-title":"The accuracy of the National Death Index when personal identifiers other than Social Security number are used","volume":"82","author":"Williams","year":"1992","journal-title":"Am J Public Health"},{"key":"10.1016\/j.ophtha.2023.07.023_bib13","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1177\/0033354920977840","article-title":"Sensitivity and specificity of the national death index for multiple causes of death in people with HIV","volume":"136","author":"Schwarcz","year":"2021","journal-title":"Public Health Rep"},{"key":"10.1016\/j.ophtha.2023.07.023_bib14","unstructured":"Kumar A, Reyes M, Young M. Hibbs Institute Newsletter. July 2019, page 3. Tyler, TX: University of Texas, Tyler."},{"key":"10.1016\/j.ophtha.2023.07.023_bib15","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1002\/art.34582","article-title":"Mortality rates in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: drug-specific comparisons in the Swedish Biologics Register","volume":"64","author":"Simard","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.ophtha.2023.07.023_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/ard.2006.067660","article-title":"All-cause and cause-specific mortality in rheumatoid arthritis are not greater than expected when treated with tumour necrosis factor antagonists","volume":"66","author":"Carmona","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2023.07.023_bib17","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1136\/ard.2008.091025","article-title":"The safety of anti-tumour necrosis factor treatments in rheumatoid arthritis: meta and exposure-adjusted pooled analyses of serious adverse events","volume":"68","author":"Leombruno","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2023.07.023_bib18","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s12325-019-01145-8","article-title":"Long-term safety of adalimumab in 29,967 adult patients from global clinical trials across multiple indications: an updated analysis","volume":"37","author":"Burmester","year":"2020","journal-title":"Adv Ther"},{"key":"10.1016\/j.ophtha.2023.07.023_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0002-9343(87)90490-6","article-title":"Malignancy following treatment of rheumatoid arthritis with cyclophosphamide. Long-term case-control follow-up study","volume":"83","author":"Baker","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/j.ophtha.2023.07.023_bib20","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1136\/ard.42.4.368","article-title":"The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up","volume":"42","author":"Baltus","year":"1983","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.ophtha.2023.07.023_bib21","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1177\/0394632015617063","article-title":"Clinic manifestations in granulomatosis with polyangiitis","volume":"29","author":"Greco","year":"2016","journal-title":"Int J Immunopathol Pharmacol"},{"key":"10.1016\/j.ophtha.2023.07.023_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ophtha.2014.08.024","article-title":"Malignancy risk in patients with inflammatory eye disease treated with systemic immunosuppressive therapy: a tertiary referral cohort study","volume":"122","author":"Yates","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ophtha.2023.07.023_bib23","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3109\/00365521.2014.1000960","article-title":"Risks for opportunistic tuberculosis infection in a cohort of 873 patients with inflammatory bowel disease receiving a tumor necrosis factor-alpha inhibitor","volume":"50","author":"Byun","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.ophtha.2023.07.023_bib24","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3390\/cancers13122881","article-title":"Male and female fertility: prevention and monitoring Hodgkin' lymphoma and diffuse large B-cell lymphoma adult survivors. A systematic review by the Fondazione Italiana Linfomi","volume":"13","author":"Viviani","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ophtha.2023.07.023_bib25","doi-asserted-by":"crossref","first-page":"4598","DOI":"10.3390\/cancers13184598","article-title":"Effect of genetic variation in CYP450 on gonadal impairment in a European cohort of female childhood cancer survivors, based on a candidate gene approach: results from the PanCareLIFE Study","volume":"13","author":"van der Perk","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ophtha.2023.07.023_bib26","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/tcm.1770050202","article-title":"Cyclophosphamide teratogenesis: a review","volume":"5","author":"Mirkes","year":"1985","journal-title":"Teratog Carcinog Mutagen"},{"key":"10.1016\/j.ophtha.2023.07.023_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/bdra.23003","article-title":"Teratogen update: methotrexate","volume":"94","author":"Hyoun","year":"2012","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ophtha.2023.07.023_bib28","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1097\/01.tp.0000252683.74584.29","article-title":"Pregnancy outcomes in solid organ transplant recipients with exposure to mycophenolate mofetil or sirolimus","volume":"82","author":"Sifontis","year":"2006","journal-title":"Transplantation"}],"container-title":["Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023005195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161642023005195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T14:13:47Z","timestamp":1758982427000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161642023005195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S0161642023005195"],"URL":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.07.023","relation":{},"ISSN":["0161-6420"],"issn-type":[{"value":"0161-6420","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Immunosuppression and the Risk of Subsequent Overall or Cancer Mortality","name":"articletitle","label":"Article Title"},{"value":"Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ophtha.2023.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Ophthalmology","name":"copyright","label":"Copyright"}]}}